Literature DB >> 11147573

Interferons and IRF-1 induce expression of the survival motor neuron (SMN) genes.

S Baron-Delage1, A Abadie, A Echaniz-Laguna, J Melki, L Beretta.   

Abstract

BACKGROUND: Spinal muscular atrophy (SMA) is a common recessive disorder, characterized by degeneration of motor neurons of the spinal cord. Deletions, conversions, or mutations of the survival motor neuron gene (SMN) are responsible for SMA. A highly homologous centromeric copy of the SMN gene (SMNc) remains intact in SMA patients. However, there is an inverse correlation between the amount of the SMNc gene product and the clinical severity of the disease. An understanding of SMN and SMNc gene regulation is, therefore, an important step towards therapy for SMA.
RESULTS: We identified a candidate Interferon-Stimulated Response Element (ISRE), overlapping with an Interferon Regulatory Factors binding motif (IRF-E) in the promoter region of SMN and SMNc genes. Both ISRE and IRF-E motifs are involved in mediating transcriptional induction of interferon-stimulated gene expression. We, therefore, investigated whether SMN and SMNc genes were regulated by interferons (IFN). Here we show that both IFN-beta and IFN-gamma rapidly induced SMN and SMNc mRNA and protein expression in various cell lines. The transcription factor IRF-1 bound to the candidate ISRE/IRF-E sequence of SMN and SMNc genes in vitro and overexpression of IRF-1 induced expression of both genes in transfection assays. IRF-1 is, therefore, at least in part responsible for the induction of SMN and SMNc by IFNs. In primary culture of fibroblasts from SMA patients, IFN-beta and IFN-gamma induced SMNc gene expression and restored protein defect.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11147573      PMCID: PMC1949924     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  13 in total

Review 1.  Motoneuron injury and repair: New perspectives on gonadal steroids as neurotherapeutics.

Authors:  Julie E Tetzlaff; Christopher B Huppenbauer; Lisa Tanzer; Thomas D Alexander; Kathryn J Jones
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

2.  The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells.

Authors:  Markus Riessland; Lars Brichta; Eric Hahnen; Brunhilde Wirth
Journal:  Hum Genet       Date:  2006-05-25       Impact factor: 4.132

3.  CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy.

Authors:  Marco A Passini; Jie Bu; Eric M Roskelley; Amy M Richards; S Pablo Sardi; Catherine R O'Riordan; Katherine W Klinger; Lamya S Shihabuddin; Seng H Cheng
Journal:  J Clin Invest       Date:  2010-03-15       Impact factor: 14.808

4.  Refined characterization of the expression and stability of the SMN gene products.

Authors:  Jérémie Vitte; Coralie Fassier; Francesco D Tiziano; Cécile Dalard; Sabrina Soave; Natacha Roblot; Christine Brahe; Pascale Saugier-Veber; Jean Paul Bonnefont; Judith Melki
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

Review 5.  Interferons, signal transduction pathways, and the central nervous system.

Authors:  Shreeram C Nallar; Dhan V Kalvakolanu
Journal:  J Interferon Cytokine Res       Date:  2014-08       Impact factor: 2.607

6.  Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy.

Authors:  Matthew E R Butchbach; Jasbir Singh; Margrét Thorsteinsdóttir; Luciano Saieva; Elzbieta Slominski; John Thurmond; Thorkell Andrésson; Jun Zhang; Jonathan D Edwards; Louise R Simard; Livio Pellizzoni; Jill Jarecki; Arthur H M Burghes; Mark E Gurney
Journal:  Hum Mol Genet       Date:  2009-11-06       Impact factor: 6.150

7.  Identification of a novel cyclic AMP-response element (CRE-II) and the role of CREB-1 in the cAMP-induced expression of the survival motor neuron (SMN) gene.

Authors:  Sarmila Majumder; Saradhadevi Varadharaj; Kalpana Ghoshal; Umrao Monani; Arthur H M Burghes; Samson T Jacob
Journal:  J Biol Chem       Date:  2004-01-23       Impact factor: 5.157

Review 8.  Therapeutics development for spinal muscular atrophy.

Authors:  Charlotte J Sumner
Journal:  NeuroRx       Date:  2006-04

9.  Characterization of the survival motor neuron (SMN) promoter provides evidence for complex combinatorial regulation in undifferentiated and differentiated P19 cells.

Authors:  Raphaël Rouget; François Vigneault; Circé Codio; Camille Rochette; Isabelle Paradis; Régen Drouin; Louise R Simard
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

10.  Detection of human survival motor neuron (SMN) protein in mice containing the SMN2 transgene: applicability to preclinical therapy development for spinal muscular atrophy.

Authors:  Virginia B Mattis; Matthew E R Butchbach; Christian L Lorson
Journal:  J Neurosci Methods       Date:  2008-08-15       Impact factor: 2.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.